Diabetes; Diet and Weight Loss; Today's Healthcare; Pharmacology; Workplace Health; Diseases and Conditions; Personalized Medicine; Public Health Education

Poison control calls related to GLP-1 receptor agonists (GLP-1RAs) surged from roughly 1,000-1,500 cases annually before 2021 to over 8,000 cases by 2023, according to research led by Jordan Miller and David Han of UT San Antonio. The spike correlates with the 2021 FDA approval of semaglutide for chronic weight management, which expanded the drug’s … Read more